Hyponatremia and Syndrome of Inappropriate Antidiuretic Hormone Secretion in Kawasaki Disease |
Lim, Goh-Woon
(Department of Pediatrics, Ewha Womans University School of Medicine)
Lee, Mi-Na (Department of Pediatrics, Ewha Womans University School of Medicine) Kim, Hae-Soon (Department of Pediatrics, Ewha Womans University School of Medicine) Hong, Young-Mi (Department of Pediatrics, Ewha Womans University School of Medicine) Sohn, Se-Jung (Department of Pediatrics, Ewha Womans University School of Medicine) |
1 | Dahdah N, Siles A, Fournier A, et al. Natriuretic peptide as an adjunctive diagnostic test in the acute phase of Kawasaki disease. Pediatr Cardiol 2009;30:810-7. DOI ScienceOn |
2 | Ohta K, Seno A, Shintani N, et al. Increased levels of urinary interleukin-6 in Kawasaki disease. Eur J Pediatr 1993;152:647-9. DOI ScienceOn |
3 | Gupta M, Noel GJ, Schaefer M, Friedman D, Bussel J, Johann-Liang R. Cytokine modulation with immune gamma-globulin in peripheral blood of normal children and its implications in Kawasaki disease treatment. J Clin Immunol 2001;21:193-9. DOI ScienceOn |
4 | Terai M, Honda T, Yasukawa K, Higashi K, Hamada H, Kohno Y. Prognostic impact of vascular leakage in acute Kawasaki disease. Circulation 2003;108:325-30. DOI ScienceOn |
5 | Duke T, Molyneux EM. Intravenous fluids for seriously ill children: time to reconsider. Lancet 2003;362:1320-3. DOI ScienceOn |
6 | Harada K. Intravenous gamma-globulin treatment in Kawasaki disease. Acta Paediatr Jpn 1991;33:805-10. DOI |
7 | Kobayashi T, Inoue Y, Takeuchi K, et al. Prediction of intravenous immunoglobulin unresponsiveness in patients with Kawasaki disease. Circulation 2006;113:2606-12. DOI ScienceOn |
8 | Eisenhut M. Changes in renal sodium transport during a systemic inflammatory response. Pediatr Nephrol 2006;21:1487-8. DOI ScienceOn |
9 | Smith PK, Goldwarer PN. Kawasaki disease in Adelaide: a review. J Paediatr Child Health 1993;29:126-31. |
10 | Koyanagi H, Nakamura Y, Yanagawa H. Lower level of serum potassium and higher level of C-reactive protein as an independent risk factor for giant aneurysms in Kawasaki disease. Acta Paediatr 1998;87:32-6. DOI ScienceOn |
11 | Suzuki H, Uemura S, Tone S, et al. Effects of immunoglobulin and gamma-interferon on the production of tumour necrosis factor-alpha and interleukin-1beta by peripheral blood monocytes in the acute phase of Kawasaki disease. Eur J Pediatr 1996;155:291-6. DOI ScienceOn |
12 | Boomsma F, van den Meiracker AH. Plasma A- and B-type natriuretic peptides: physiology, methodology and clinical use. Cardiovasc Res 2001;51:442-9. DOI ScienceOn |
13 | Fujiwara T, Fujiwara H, Takemura G, et al. Expression and distribution of atrial natriuretic polypeptide in the ventricles of children with myocarditis and/or myocardial infarction secondary to Kawasaki disease: immunohistochemical study. Am Heart J 1990;120:612-8. DOI ScienceOn |
14 | Maury CP, Salo E, Pelkonen P. Circulating interleukin-1beta in patients with Kawasaki disease. N Engl J Med 1988;319:1670-1. DOI ScienceOn |
15 | Mastorakos G, Weber JS, Magiakou MA, Gunn H, Chrousos GP. Hypothalamic-pituitary-adrenal axis activation and stimulation of systemic vasopressin secretion by recombinant Interleukin-6 in humans: potential implications for the syndrome of inappropriate vasopressin secretion. J Clin Endocrinol Metab 1994;79:934-9. DOI ScienceOn |
16 | Ohta M, Ito S. Hyponatremia and inflammation. Rinsho Byori 1999;47:408-16. |
17 | Dajani AS, Taubert KA, Gerber MA, et al. Diagnosis and therapy of Kawasaki disease in children. Circulation 1993;87:1776-80. DOI ScienceOn |
18 | Berry PL, Belsha CW. Hyponatremia. Pediatr Clin North Am 1990;37:351-63. DOI |
19 | Research committee on Kawasaki disease. Report of subcommittee on standardization of diagnostic criteria and reporting of coronary artery lesions in Kawasaki disease. Ministry of Health and Welfare: Tokyo;1984. |
20 | Watanabe T, Abe Y, Sato S, Uehara Y, Ikeno K, Abe T. Hyponatremia in Kawasaki disease. Pediatr Nephrol 2006;21:778-81. DOI ScienceOn |
21 | Holliday MA, Segar WE. The maintenance need for water in parenteral fluid therapy. Pediatrics 1957;19:823-32. |
22 | Cho HK, Sohn JA, Kim HS, Sohn S. Low T3 syndrome in Kawasaki disease: relation to serum levels of tumor necrosis factor-alpha, interleukin-6 and NT-proBNP. Korean J Pediatr 2009;52:234-41. DOI ScienceOn |
23 | Lee H, Kim H, Kim HS, Sohn S. NT-proBNP: a new diagnostic screening tool for Kawasaki disease. Korean J Pediatr 2006;49:539-44. DOI |
24 | Nakabayashi Y, Shimizu T. Hyponatremia in Kawasaki disease. Nippon Shoni Jinzobyo Gakkai Zasshi 2002;15:83-7. DOI |
25 | Laxer RM, Petty RE. Hyponatremia in Kawasaki disease. Pediatrics 1982;70:655. |
26 | Lapointe N, Chad Z, Lacroix J, et al. Kawasaki disease: association with uveitis in seven patients. Pediatrics 1982;69:376-8. |
27 | Mine K, Takaya J, Hasui M, Ikemoto Y, Teraguchi M, Kobayashi Y. A case of Kawasaki disease associated with syndrome of inappropriate secretion of antidiuretic hormone. Acta Paediatr 2004;93:1547-9. DOI ScienceOn |
28 | Kim DS. Serum interleukin-6 in Kawasaki disease. Yonsei Med J 1992;33:183-8. DOI |